Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources

Radiotherapy and Oncology

Volumn 71, Issue 1, 2004, Pages 99-108

  Marijnissen, Johannes P A ^a   Coen, Veronique L M A ^a   Van Der Giessen, Wim J ^a   De Pan, Connie ^a   Serruys, Patrick W ^a   Levendag, Peter C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Beta radiation; Coronary bifurcation; Dosimetry; Endovascular brachytherapy; Restenosis; Treatment planning

Indexed keywords

IRIDIUM 192; PHOSPHORUS 32; STRONTIUM 90; YTTRIUM 90;

ARTICLE; BETA RADIATION; COMPUTER PROGRAM; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; DOSIMETRY; GEOMETRY; MAXIMUM ALLOWABLE CONCENTRATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BETA RAYS; BRACHYTHERAPY; CORONARY RESTENOSIS; CORONARY VESSELS; HUMANS; IRIDIUM RADIOISOTOPES; MODELS, BIOLOGICAL; PHOSPHORUS RADIOISOTOPES; RADIOTHERAPY DOSAGE; STRONTIUM RADIOISOTOPES; YTTRIUM RADIOISOTOPES;

EID: 1842422597     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.12.009     Document Type: Article

References (20)

1. Coen V.L., Marijnissen J.P., Ligthart J.M., et al. Inaccuracy in manual multisegmental irradiation in coronary arteries. Radiother Oncol. 63:(1):2002;89-95.
2. Cygler J.E., Esche B., Angers C., et al. Endovascular brachytherapy strategies for treatment of coronary restenosis at sites of arterial bifurcation. [Abstract]. Radiother Oncol. 64:(Suppl. 1):2002;S228.
3. Forrester J.S., Fishbein M., Helfant R., et al. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Colloid Cardiol. 17:(3):1991;758-769.
4. Giap H.B., Bendre D.D., Huppe G.B., Teirstein P., Tripuraneni P. Source displacement during the cardiac cycle in coronary endovascular brachytherapy. Int J Radiat Oncol Biol Phys. 49:(1):2001;273-277.
5. Gruentzig A.R., King S.B. III, Schlumpf M., Siegenthaler W. Long-term follow-up after percutaneous transluminal coronary angioplasty: the early Zurich experience. N Engl J Med. 316:(18):1987;1127-1132.
6. Holmes D.R. Jr, Vlietstra R.E., Smith H.C., et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol. 53:(12):1984;77C-81C.
7. Kim H.S., Waksman R., Chan R.C., et al. Safety and efficacy of manual stepping and overlapping of beta-emitter for diffuse in-stent restnosis. Cardiovasc Radiat Med. 3:(1):2002;56-59.
8. King S.B., Williams D.O., Chougule P., et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty. Results of the beta energy restenosis trial (BERT). Circulation. 97:(20):1998;2025-2030.
9. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 344:(4):2001;250-256.
10. Nath R., Amols H., Coffey C., et al. Intravascular brachytherapy physics: report of the AAPM radiation therapy committee task group no. 60. Med Phys. 26:(2):1999;119-152.
11. Nobuyoshi M., Kimura T., Nosaka H., et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Colloid Cardiol. 12:(3):1988;616-623.
12. Potter R., van Limbergen E., Dries W., et al. Recommendations of the EVA GEC ESTRO working group: prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. Radiother Oncol. 59:(3):2001;339-360.
13. Raizner A.E., Oesterle S.N., Waksman R., et al. Inhibition of restenosis with beta-emitting radiotherapy. Report of the proliferation reduction with vascular energy trial (PREVENT). Circulation. 102:(9):2000;951-958.
14. Sabate M., Costa M.A., Kozuma K., et al. Geographical miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation. 101:(21):2000;2467-2471.
15. Syeda B., Siostrzonek P., Schmid R., et al. Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Colloid Cardiol. 40:(7):2002;1225-1231.
16. Teirstein P.S., Massullo V., Jani S.K., et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 336:(24):1997;1697-1703.
17. Teirstein P.S., Massullo V., Jani S.K., et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomised clinical trial. Circulation. 101:(4):2000;360-365.
18. Waksman R., Bhargava B., Chan R.C., et al. Safety and efficacy of manual stepping and overlapping of a β-emitter for diffuse in-stent restenosis lesions. [Abstract]. J Am Colloid Cardiol. 35:(2, Suppl. A):2000;21.
19. Waksman R., Bhargava B., White L.R., et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation. 101:(16):2000;1895-1898.
20. Waksman R., White L.R., Chan R.C., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits. Recurrence in patients with in-stent restenosis. Circulation. 101:(18):2000;2165-2171.